FDA moves to cut expert panel input on new drugs
(By: Alexandra Murphy for Becker’s Hospital Review) The FDA is moving to scale back its long-standing use of expert panels
Read More
(By: Alexandra Murphy for Becker’s Hospital Review) The FDA is moving to scale back its long-standing use of expert panels
Read More